Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Front Immunol 15:1495137
Scott Isaacs, MD, FACP, FACEs Post Reduced-frequency GLP-1 as a maintenance strategy: in this case series, patients who tapered from weekly semaglutide/tirzepatide to less frequent dosing maintained weight loss, body composition, and metabolic syndrome gains, supporting structured de-escalation to lower burden without sacrificing efficacy
Cell (2017) This landmark Cell publication from Erasmus University Medical Center introduced FOXO4-DRI as a senolytic peptide that selectively eliminates senescent cells by disrupting the FOXO4-p53 interaction
Although nanotechnology has enhanced cancer treatment, the use of nanomaterials in this technology may exhibit cytotoxicity (122)
US$ 20.17
US$ 25.60
US$ 25.25
US$ 24.24
,aspect=ignore)
US$ 20.94
,aspect=ignore)
US$ 21.20
